🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for PSC

An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis NCT05335603n/a1 site📍 Hvidovre University of Copenhagen FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis NCT06286709Phase 25 sites📍 Birmingham📍 London📍 London University of Birmingham · Tests: Faecal Microbiota Transplant, FMT Placebo MRI Based Biomarkers in Pediatric Autoimmune Liver Disease NCT03175471n/a1 site📍 Cincinnati Children's Hospital Medical Center, Cincinnati PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) NCT06920628Phase 11 site📍 Bethesda National Institute of Mental Health (NIMH) · Tests: 11C-PS13 Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin NCT02137668Phase 11 site📍 Sacramento Sacramento Pediatric Gastroenterology · Tests: Oral Vancomycin Brain Stimulation in Long COVID NCT07278206NA1 site📍 Amsterdam Amsterdam UMC, location VUmc · Tests: Repetitive Transcranial Magnetic Stimulation, Sham device Vancomycin in Primary Sclerosing Cholangitis in Italy NCT05876182Phase 21 site📍 Monza University of Milano Bicocca · Tests: Oral Vancomycin, Placebo Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation NCT06905054Phase 21 site📍 Scottsdale Mayo Clinic · Tests: Fenofibrate (drug), Blood draw for the laboratory assessment, MRI using a hepatobiliary phase contrast agent (Gd-EOB-DP… Swiss Primary Sclerosing Cholangitis Cohort Study NCT03146936n/a21 sites📍 Lugano📍 Basel📍 Basel Fondazione Epatocentro Ticino Low Dose Sirolimus in People With Post-Acute Sequelae of COVID-19 (PASC) Long COVID-19 NCT06960928Phase 31 site📍 New York Icahn School of Medicine at Mount Sinai · Tests: Low-dose sirolimus, Placebo Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2 NCT05833217NA2 sites📍 Palo Alto📍 Palo Alto Stanford University · Tests: Adipose Tissue Biopsy, Steady State Plasma Glucose (SSPG) Test Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2 NCT07278388NA1 site📍 Baltimore Hugo W. Moser Research Institute at Kennedy Krieger, Inc. · Tests: Physical Fatigue Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health NCT04573062n/a1 site📍 Bethesda National Institute of Neurological Disorders and Stroke (NI… Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients NCT04753996n/a1 site📍 Rochester Mayo Clinic Primary Sclerosing Cholangitis in Children NCT04181138n/a12 sites📍 Los Angeles📍 Aurora📍 Atlanta Arbor Research Collaborative for Health Biodegradable Stents in Primary Sclerosing Cholangitis NCT07607353NA1 site📍 London King's College Hospital NHS Trust · Tests: archimedes stent Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome NCT06519162n/a1 site📍 Daejeon Chungnam National University Hospital A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis NCT07387549Phase 3231 sites📍 Chandler📍 Phoenix📍 Coronado Ipsen · Tests: Elafibranor, Placebo Biobank for Cholestatic Liver Diseases. NCT03445585n/a1 site📍 Rochester Mayo Clinic LIFT: Life Improvement Trial NCT06366724Phase 21 site📍 Boston Brigham and Women's Hospital · Tests: Pyridostigmine, Low-Dose Naltrexone, Placebo Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai) NCT06767605n/a1 site📍 Barcelona Asociación Española para el Estudio del Hígado A-LiNK: Improving Outcomes in Autoimmune Liver Disease NCT05750498n/a8 sites📍 Palo Alto📍 Indianapolis📍 St Louis Children's Hospital Medical Center, Cincinnati · Tests: No interventions Osteopathic Manipulative Therapy Effects on Post-Acute Sequelae of COVID-19 (PASC) or Long COVID NCT06883513NA1 site📍 Louisville University of Louisville · Tests: Osteopathic Manipulative Therapy Long-COVID protocol, Osteopathic Manipulative Therapy NOT Long-COVID treatment protocol Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis. NCT05295680Phase 22 sites📍 Redwood City📍 Stanford Aparna Goel · Tests: Hymecromone A Study of SIPLIZUMAB in AILD and LT Patients NCT06455280Phase 11 site📍 New York Elizabeth C. Verna · Tests: Siplizumab A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC NCT06699121Phase 27 sites📍 Sacramento📍 Aurora📍 Iowa City LISCure Biosciences · Tests: LB-P8 low-dose, LB-P8 high-dose, Placebo Registry for Advanced Endoscopy NCT05187312n/a1 site📍 Stockholm Region Stockholm · Tests: Endoscopic retrograde Cholangio- pancreatography, Endoscopic ultrasound Long-Term Study of COVID-19 Infection and Long COVID NCT07781501n/a1 site📍 Chapel Hill University of North Carolina, Chapel Hill · Tests: This study is observational. Only patients who have previously tested positive for SARS-CoV-2 infection or are experien… National Database on Primary Sclerosing Cholangitis (PSC) NCT05618145n/a63 sites📍 Ancona📍 Bari📍 Bergamo University of Milano Bicocca · Tests: Clinical information MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease NCT03178630n/a1 site📍 Cincinnati Children's Hospital Medical Center, Cincinnati
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy